MedPath

Lidocaine Hydrochloride

LIDOCAINE HYDROCHLORIDE JELLY USP, 2A STERILE, WATER-SOLUBLE, TOPICAL ANESTHETIC

Approved
Approval ID

ddaee8bc-f55c-48b1-9b0e-ad1e2dd15a2c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 9, 2023

Manufacturers
FDA

Henry Schein, Inc.

DUNS: 012430880

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

lidocaine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0404-9899
Application NumberANDA086283
Product Classification
M
Marketing Category
C73584
G
Generic Name
lidocaine hydrochloride
Product Specifications
Route of AdministrationTOPICAL
Effective DateNovember 9, 2023
FDA Product Classification

INGREDIENTS (1)

LIDOCAINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine Hydrochloride - FDA Drug Approval Details